Filing search / Olema Pharmaceuticals, Inc. / "Reputational"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Reputational"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

19 results

Newest first Best match first

10-Q

2024 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational … , reputational harm, administrative burdens and diminished profits and future earnings. Healthcare providers and third-party payors play a primary role

6 Aug 24

4:15pm

10-Q

2024 Q1

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm … , civil penalties, contractual damages, exclusion from governmental healthcare programs, reputational harm, administrative burdens and diminished profits

8 May 24

4:15pm

10-K

2023 FY

OLMA Olema Pharmaceuticals, Inc.

Annual report

and Table of Contents penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; or other adverse … damages, reputational harm, administrative burdens, diminished profits and future earnings, and the curtailment or restructuring of our operations, any

11 Mar 24

4:15pm

10-Q

2023 Q3

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

, criminal sanctions, civil penalties, contractual damages, exclusion from governmental healthcare programs, reputational harm, administrative burdens … in government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm

7 Nov 23

4:12pm

10-Q

2023 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

from governmental healthcare programs, reputational harm, administrative burdens and diminished profits and future earnings. Healthcare providers … , integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings and the curtailment

8 Aug 23

4:12pm

10-Q

ptug 08tkoystc

Quarterly report

9 May 23

4:08pm

10-Q

wgoxygmp

Quarterly report

8 Nov 22

4:45pm

10-Q

1ae dypsw

Quarterly report

9 Aug 22

12:00am

10-Q

zilfh vzqbgz8o4

Quarterly report

9 May 22

4:44pm

10-K

4y5dl9ke8a03k9jd

Annual report

28 Feb 22

4:56pm

10-Q

tespp

Quarterly report

10 Nov 21

4:21pm

10-Q

glt3xid3p q71qgh

Quarterly report

10 Aug 21

4:18pm

Prospectus supplement with pricing info

IPO registration (amended)

Draft registration statement (amended)

Draft registration statement

12:00am

Filing search / Olema Pharmaceuticals, Inc. / "Reputational"

19 results

Top filers

Top filing types

Recent filing years